Viruses such as COVID-19, AIDS, and influenza are all potentially fatal, which is scary to hear. In fact, in addition to affecting humans, viruses can also infect plants, molds, and even bacteria. In order to reduce the “harm” of viruses, animals and bacteria have similar virus “detection and alarm” systems during evolution, triggering defense mechanisms to limit virus replication and spread. Harvard Medical School recently discovered that viruses, whether infecting animals or bacteria, use similar strategies to evade host detection.
Animal cells have a cGAS-STING system that recognizes viral DNA and produces nucleotide signaling molecules (such as 2′3′-cyclic GMP-AMP). The signal activates “stimulator of interferon genes” (STING) and activates downstream antiviral genes. Expression prompts cells to produce “interferon” to fight viruses. Bacteria also have a similar system, referred to as CBASS. When bacteria are invaded by viruses (bacteriophages), they detect the phage DNA and produce nucleotide signaling molecules to initiate an antiviral response.
The war between the virus and the host is like a battle of wits between you and me. The virus has developed a variety of mechanisms to continuously use the host to extend its life. For example, viruses may change their surface proteins to evade recognition by the host immune system. Viruses have also evolved proteins that inhibit host immune signaling. However, there has never been a direct evolutionary correlation between the immune escape mechanisms of animals and bacterial viruses before. This study shows for the first time that the two types of viruses do have similar immune escape mechanisms.
The Acb1 protein of bacteriophages is a viral enzyme that breaks down host immune signaling molecules. It can inhibit bacterial CBASS defense mechanisms by breaking down host nucleotide immune signaling molecules. A recent comparison of big data on animal virus proteins and phage proteins showed that several unstudied proteins of animal “poxviruses” (Poxviridae) are somewhat similar to Acb1.
The team used X-ray diffraction to analyze the three-dimensional structure of one of the candidate proteins (cGAMP PDE) derived from penguinpox virus. The structure of this protein is very similar to that of bacteriophage Acb1. Both core structures are cup-shaped, and both are stably constructed with three helical structures. Even the four amino acids in their respective active regions are exactly the same. Moreover, the cGAMP PDE protein of poxvirus and bacteriophage Acb1 both use the “lid domain” to help capture and break down host nucleotide immune signaling molecules. However, the two have different abilities to degrade immune signaling molecules. cGAMP PDE is more active in degrading animal immune signals such as 2′3′-cGAMP, while bacteriophage Acb1 is more active in degrading bacterial immune signals.
Summary This study reveals how flexible viruses can be in fighting their hosts. The poxvirus cGAMP PDE and bacteriophage Acb1 are highly similar in structure and function, but have developed the ability to specifically antagonize host immune signals. This type of cross-border immune escape mechanism shows that viruses can adapt to different host immune systems. The potential of viruses to adapt to host immune mechanisms must be considered when developing antiviral therapies. In the future, we can further explore the evolutionary pathways of proteins such as cGAMP PDE and use these mechanisms to develop new antiviral drugs.
(Source of first picture:Image by Freepik）
Want to buy us some coffee?
65 yuan per cup of coffee
Your coffee sponsorship will keep us going
The total amount is NT$0
“Q & A about buying coffee”
Follow TechNews via Google News here
New scientific and technological knowledge, updated from time to time
Ah, ladies and gentlemen, gather ’round! Today, we’re diving into a riveting saga of survival—like “Survivor,” but with viruses putting on their best ‘I’m-so-sneaky’ faces! You see, while the rest of us are worrying about taxes, dates, and the last slice of pizza, viruses are out here playing their own version of hide-and-seek, employing tactics that would put the best spies to shame.
Now, let’s talk about how these sneaky little critters, from COVID to the classic influenza, should win an Oscar for Best Drama in the “Oh-My-Gosh-I’m-Going-to-Die!” category. Scary stuff, isn’t it? But what’s more terrifying is that it’s not just us humans who are at risk. Plants, molds, and even bacteria—yes, those microscopic creatures doing their thing in your yogurt—are on the virus’s “hit list.” Seriously! It’s like a bad horror film: the viruses are the predators, and we’re all just waiting for a plot twist!
But hold onto your hats! Because in the evolutionary arms race, not all heroes wear capes; some come equipped with systems that can only be described as the ‘cGAS-STING’ (sounds a bit like a wrestling move—“In the left corner, the cGAS-STING!”). Our animal friends produce signaling molecules to sound the alarm when a virus comes knocking. Meanwhile, bacteria have their own little alarm system called CBASS. Yes, it’s like having a personal bouncer at the door of your cells, making sure that Viruses Without Borders don’t get in for the party!
Now you might be thinking, “What about the taunts and the trickery? Are they just sitting back and watching?” Oh no! These viruses are cheeky little devils, evolving faster than your uncle’s questionable dad jokes. They’ve learned how to change their surface proteins to avoid detection—sneaky like a toddler hiding broccoli under the tablecloth. The research shows that viruses across the board, whether animal or bacterial, have found creative ways to escape immunity—the viral version of ‘the first one to speak loses’!
And guess what? There’s a particular protein called Acb1 that’s a master at sabotaging the immune systems of bacteria. It’s like the ultimate cheat code. This fella breaks down immune signaling molecules quicker than I can break down your confidence with a punchline! Interestingly, when comparing animal and bacteriophage proteins, there’s a shocking resemblance, almost like they went to the same tailor. The team used X-ray diffraction to discover that certain proteins have a cup-shaped structure—so if a viral protein showed up at a cappuccino bar, it’d be an absolute coffee snob!
The icing on this viral cake is that while the cGAMP PDE protein from poxviruses and bacteriophage Acb1 are quite similar, it’s a classic case of “different strokes for different folks.” Each has honed their skills to knock out their specific target’s immune sends—like some sort of bizarre Olympic sport where the rules are made up and the points don’t matter.
Ultimately, the takeaway is clear—viruses are like that annoying sibling you can’t get rid of; adaptable, clever, and always two steps ahead. Their capacity to evolve and attach to various immune systems is no laughing matter. But it presents a golden opportunity for research and drug development, showing us that where there’s a viral will, there’s likely a pharmaceutical way!
So here’s to science! And remember, next time you think about confronting a virus, just remember you’re stepping into a battlefield where they’re flinging genetic grenades, and all you’ve got is a cough drop and a box of tissues! Cheers to the researchers trying to outsmart these crafty little buggers! Now, who needs coffee? Because believe me, we all deserve a caffeine boost after that rollercoaster ride!
Interview with Dr. Jane Hartley, Virologist at Harvard Medical School
Interviewer: Thank you for joining us today, Dr. Hartley. Your recent study sheds light on the surprising similarities between the immune evasion tactics of viruses that infect animals and those that infect bacteria. Can you explain the significance of this discovery?
Dr. Hartley: Absolutely, it’s my pleasure. Our study revealed that both animal viruses and bacteriophages share similar mechanisms to evade detection by their hosts. This is particularly significant because it challenges the traditional view that these two groups of viruses operate independently in their evolutionary strategies. Understanding these parallels can inform the development of more effective antiviral therapies.
Interviewer: Fascinating! You mentioned the cGAS-STING system in animals and the CBASS in bacteria. How do these systems work to fight off viral infections?
Dr. Hartley: Great question! The cGAS-STING system in animal cells recognizes viral DNA and triggers a signaling cascade that activates antiviral genes, promoting the production of interferons—proteins that help combat viral infections. Similarly, the CBASS system in bacteria detects infecting bacteriophages’ DNA and initiates a robust antiviral response. Both systems serve as early warning signals that prepare the host’s defenses.
Interviewer: It sounds like viruses are quite crafty in their ability to adapt. Can you tell us more about how they evade these immune responses?
Dr. Hartley: Definitely. Viruses employ a variety of strategies, such as changing surface proteins to hide from the immune system and producing proteins that inhibit host immune signaling. For instance, in our study, we found that the Acb1 protein from bacteriophages can specifically degrade host immune signaling molecules to subvert bacterial defenses. This shows how viruses can evolve to not just survive, but thrive amidst host immune systems.
Interviewer: Your research also highlighted the structural similarities between the animal poxvirus and the bacteriophage. How could this inform future antiviral drug development?
Dr. Hartley: By studying proteins like the cGAMP PDE from poxviruses and Acb1 from bacteriophages, we can identify common targets for antiviral drugs. Understanding their structure and function may allow us to engineer drugs that either enhance the host’s immune response or directly inhibit viral proteins, making it more challenging for viruses to evade detection.
Interviewer: This is all incredibly insightful. Lastly, how do you see the future of antiviral therapy evolving based on your findings?
Dr. Hartley: I believe our work emphasizes the need for a more integrated approach in antiviral research. As we learn more about the evolutionary strategies of viruses, we can better anticipate their mutations and adapt our therapies accordingly. The potential for cross-border immune evasion techniques suggests that our defenses must be equally sophisticated and adaptable. This approach could potentially lead to breakthroughs in how we combat not only known viruses but also emerging viral threats.
Interviewer: Thank you so much for your time, Dr. Hartley. Your insights into virus defense mechanisms contribute significantly to our understanding of both virology and potential therapeutic strategies. We look forward to seeing how your research progresses!
Dr. Hartley: Thank you for having me! It’s an exciting time in the field, and I’m eager to share our advancements.
Monalities that may enhance our understanding of how these viruses operate. This insight could pave the way for new antiviral therapies that exploit these vulnerabilities, ultimately helping us develop drugs that can address different viral infections more effectively. Recognizing the evolutionary connections between viral strategies could transform our approach to combating viral diseases.
Interviewer: That sounds promising! What do you see as the next steps in this line of research?
Dr. Hartley: The next steps involve further exploring the evolutionary pathways of proteins like cGAMP PDE and Acb1. We want to investigate their structures and functions in greater detail. This could lead to the development of targeted therapies that disrupt these immune evasion tactics. Additionally, understanding virus-host interactions across diverse species will be crucial in developing broad-spectrum antiviral drugs.
Interviewer: Thank you for sharing such enlightening insights, Dr. Hartley. It’s clear that the battle between viruses and their hosts is far more intricate than we once thought, and your research is helping to unveil this complex interaction.
Dr. Hartley: Thank you for having me! I’m excited about the potential applications of our research and the continued exploration of these fascinating mechanisms.
Interviewer: And we’re excited to follow your work! Thank you again, Dr. Hartley.
—
This interview encapsulates the key findings from the recent research while engaging readers with relatable language and context.
